Development Level

Tclin 5 | 602
Tbio 1 | 10,625
Tchem 1 | 1,890

Disease

Major Depressive Disorder 5 | 106
lung adenocarcinoma 5 | 2,713
Alzheimer's disease 4 | 644
Attention deficit hyperactivity disorder 4 | 156
Dementia 4 | 129
Parkinson's disease 4 | 364
Schizophrenia 4 | 501
lung cancer 4 | 4,466
pancreatic ductal adenocarcinoma liver metastasis 4 | 1,795
Alcohol dependence 3 | 107
Autistic Disorder 3 | 320
Depressive disorder 3 | 48
Parkinson Disease 3 | 102
Toxic encephalopathy 3 | 131
breast carcinoma 3 | 1,614
colon cancer 3 | 1,475
invasive ductal carcinoma 3 | 2,950
lung carcinoma 3 | 2,844
non-small cell lung cancer 3 | 2,798
ovarian cancer 3 | 8,484
pituitary cancer 3 | 1,972
psoriasis 3 | 6,685
Acute kidney injury 2 | 65
Amphetamine-Related Disorders 2 | 74
Atypical depressive disorder 2 | 6
Bipolar Disorder 2 | 266
Breast cancer 2 | 3,094
Cancer 2 | 2,346
Cocaine dependence 2 | 24
Conduct disorder 2 | 25
Constipation 2 | 43
Dysthymic disorder 2 | 14
Endometriosis 2 | 535
Hepatic encephalopathy 2 | 25
Huntington Disease 2 | 12
Hypertensive disorder 2 | 58
Hypotension 2 | 53
Liver disease 2 | 219
Migraine 2 | 79
Oppositional defiant disorder 2 | 16
Personality disorder 2 | 25
Pheochromocytoma 2 | 22
Prenatal Exposure Delayed Effects 2 | 9
Prostatic Neoplasms 2 | 471
Schizoaffective disorder 2 | 33
Substance abuse 2 | 55
Substance-Related Disorders 2 | 114
Sudden infant death syndrome 2 | 33
atypical teratoid / rhabdoid tumor 2 | 4,369
glioblastoma 2 | 5,572
malignant mesothelioma 2 | 3,162
obsessive-compulsive disorder 2 | 34
pancreatic cancer 2 | 2,300
pilocytic astrocytoma 2 | 3,086
posterior fossa group A ependymoma 2 | 1,511
sonic hedgehog group medulloblastoma 2 | 1,482
Agoraphobia 1 | 16
Alcoholic Intoxication, Chronic 1 | 41
Anemia, Megaloblastic 1 | 4
Antisocial personality disorder 1 | 9
Anxiety Disorders 1 | 37
Asperger syndrome 1 | 35
Autoimmune hepatitis 1 | 13
Bradycardia 1 | 24
Brain disease 1 | 83
Bruxism 1 | 19
Bulimia nervosa 1 | 15
Cardioversion of Atrial Fibrillation 1 | 9
Delusional disorder 1 | 10
Diabetic peripheral neuropathy 1 | 4
Diarrhea 1 | 155
Dyspepsia 1 | 34
Dystonia 1 | 77
Eating disorder 1 | 24
Esophagitis 1 | 26
Exhibitionism 1 | 7
Fibromyalgia 1 | 22
Gastritis 1 | 44
Gaucher disease type 3 1 | 76
Generalized anxiety disorder 1 | 29
Gilles de la Tourette syndrome 1 | 47
Hepatitis C 1 | 90
Heroin dependence 1 | 30
Irritable bowel syndrome 1 | 59
Kidney Failure, Chronic 1 | 45
Melancholia 1 | 12
Metastatic Prostate Carcinoma 1 | 18
Mood Disorders 1 | 3
Mood disorder 1 | 10
Muscle Rigidity 1 | 5
Nicotine dependence 1 | 53
Panic disorder 1 | 55
Plaque, Amyloid 1 | 2
Premenstrual dysphoric disorder 1 | 8
Primary pulmonary hypertension 1 | 5
Pseudobulbar affect 1 | 5
Pulmonary hypertension 1 | 52
Substance Withdrawal Syndrome 1 | 52
Weight Gain 1 | 87
interstitial lung disease 1 | 291

Tissue

Blood and immune system 7 | 17,995
Cardiovascular System 7 | 17,958
Digestive Tract 7 | 18,473
Endocrine System 7 | 18,512
Female tissues 7 | 18,647
Liver and Pancreas 7 | 18,136
Male tissues 7 | 17,969
Nervous System 7 | 18,561
Respiratory system 7 | 17,484
Skin and soft tissues 7 | 18,115
Urinary Tract 7 | 18,444

Target Family

Enzyme 5 | 4,146
Non-IDG 1 | 11,971
Transporter 1 | 473

PathwayCommons: smpdb Pathway

Citalopram Metabolism Pathway 7 | 7
Phenytoin (Antiarrhythmic) Act... 79 | 79
Lidocaine (Antiarrhythmic) Act... 61 | 61
Carvedilol Action Pathway 60 | 60
Labetalol Action Pathway 60 | 60
Muscle/Heart Contraction 60 | 60
Acebutolol Action Pathway 59 | 59
Alprenolol Action Pathway 59 | 59
Amiodarone Action Pathway 59 | 59
Amlodipine Action Pathway 59 | 59
Arbutamine Action Pathway 59 | 59
Atenolol Action Pathway 59 | 59
Betaxolol Action Pathway 59 | 59
Bevantolol Action Pathway 59 | 59
Bisoprolol Action Pathway 59 | 59
Bopindolol Action Pathway 59 | 59
Bupranolol Action Pathway 59 | 59
Carteolol Action Pathway 59 | 59
Diltiazem Action Pathway 59 | 59
Disopyramide Action Pathway 59 | 59
Dobutamine Action Pathway 59 | 59
Epinephrine Action Pathway 59 | 59
Esmolol Action Pathway 59 | 59
Felodipine Action Pathway 59 | 59
Flecainide Action Pathway 59 | 59
Fosphenytoin (Antiarrhythmic) ... 59 | 59
Ibutilide Action Pathway 59 | 59
Isoprenaline Action Pathway 59 | 59
Isradipine Action Pathway 59 | 59
Levobunolol Action Pathway 59 | 59
Metipranolol Action Pathway 59 | 59
Metoprolol Action Pathway 59 | 59
Mexiletine Action Pathway 59 | 59
Nadolol Action Pathway 59 | 59
Nebivolol Action Pathway 59 | 59
Nifedipine Action Pathway 59 | 59
Nimodipine Action Pathway 59 | 59
Nisoldipine Action Pathway 59 | 59
Nitrendipine Action Pathway 59 | 59
Oxprenolol Action Pathway 59 | 59
Penbutolol Action Pathway 59 | 59
Pindolol Action Pathway 59 | 59
Practolol Action Pathway 59 | 59
Procainamide (Antiarrhythmic) ... 59 | 59
Propranolol Action Pathway 59 | 59
Quinidine Action Pathway 59 | 59
Sotalol Action Pathway 59 | 59
Timolol Action Pathway 59 | 59
Tocainide Action Pathway 59 | 59
Verapamil Action Pathway 59 | 59
Azathioprine Action Pathway 47 | 47
Ibuprofen Action Pathway 47 | 47
Mercaptopurine Action Pathway 47 | 47
Thioguanine Action Pathway 47 | 47
Warburg Effect 45 | 45
Intracellular Signalling Throu... 38 | 38
AICA-Ribosiduria 37 | 37
Adenine phosphoribosyltransfer... 37 | 37
Adenosine Deaminase Deficiency 37 | 37
Adenylosuccinate Lyase Deficie... 37 | 37
Gout or Kelley-Seegmiller Synd... 37 | 37
Intracellular Signalling Throu... 37 | 37
Lesch-Nyhan Syndrome (LNS) 37 | 37
Mitochondrial DNA depletion sy... 37 | 37
Molybdenum Cofactor Deficiency 37 | 37
Myoadenylate deaminase deficie... 37 | 37
Purine Metabolism 37 | 37
Purine Nucleoside Phosphorylas... 37 | 37
Xanthine Dehydrogenase Deficie... 37 | 37
Xanthinuria type I 37 | 37
Xanthinuria type II 37 | 37
Fc Epsilon Receptor I Signalin... 36 | 36
Morphine Action Pathway 35 | 35
Retinol Metabolism 35 | 35
Vitamin A Deficiency 35 | 35
Celecoxib Action Pathway 34 | 34
Eplerenone Action Pathway 33 | 33
Spironolactone Action Pathway 33 | 33
Amiloride Action Pathway 32 | 32
Bendroflumethiazide Action Pat... 32 | 32
Blue diaper syndrome 32 | 32
Bumetanide Action Pathway 32 | 32
Chlorothiazide Action Pathway 32 | 32
Chlorthalidone Action Pathway 32 | 32
Cyclothiazide Action Pathway 32 | 32
Cystinuria 32 | 32
Ethacrynic Acid Action Pathway 32 | 32
Furosemide Action Pathway 32 | 32
Glucose Transporter Defect (SG... 32 | 32
Hartnup Disorder 32 | 32
Hydrochlorothiazide Action Pat... 32 | 32
Hydroflumethiazide Action Path... 32 | 32
Iminoglycinuria 32 | 32
Indapamide Action Pathway 32 | 32
Kidney Function 32 | 32
Lysinuric Protein Intolerance 32 | 32
Lysinuric protein intolerance ... 32 | 32
Methyclothiazide Action Pathwa... 32 | 32
Metolazone Action Pathway 32 | 32
Polythiazide Action Pathway 32 | 32
Quinethazone Action Pathway 32 | 32

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Amine oxidase [flavin-containing] B MAOB Tclin Enzyme -3.37979 2431.7 224
Cytochrome P450 3A7 CYP3A7 Tclin Enzyme -1.95485 85.7 134
Cytochrome P450 2C19 CYP2C19 Tchem Non-IDG -3.17457 1627.4 145
Aldehyde oxidase AOX1 Tbio Enzyme -2.62974 413.2 143
Amine oxidase [flavin-containing] A MAOA Tclin Enzyme -3.36609 2411.2 259
Cytochrome P450 2D6 CYP2D6 Tclin Enzyme -3.50005 3352.9 382
Sodium-dependent serotonin transporter SLC6A4 Tclin Transporter -3.59469 4217.5 198